DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis

[Image: see text] Visceral leishmaniasis (VL) is a parasitic disease endemic across multiple regions of the world and is fatal if untreated. Current therapies are unsuitable, and there is an urgent need for safe, short-course, and low-cost oral treatments to combat this neglected disease. The benzox...

Descripción completa

Detalles Bibliográficos
Autores principales: Mowbray, Charles E., Braillard, Stéphanie, Glossop, Paul A., Whitlock, Gavin A., Jacobs, Robert T., Speake, Jason, Pandi, Bharathi, Nare, Bakela, Maes, Louis, Yardley, Vanessa, Freund, Yvonne, Wall, Richard J., Carvalho, Sandra, Bello, Davide, Van den Kerkhof, Magali, Caljon, Guy, Gilbert, Ian H., Corpas-Lopez, Victoriano, Lukac, Iva, Patterson, Stephen, Zuccotto, Fabio, Wyllie, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591608/
https://www.ncbi.nlm.nih.gov/pubmed/34711050
http://dx.doi.org/10.1021/acs.jmedchem.1c01437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591608/
https://www.ncbi.nlm.nih.gov/pubmed/34711050
http://dx.doi.org/10.1021/acs.jmedchem.1c01437

Ejemplares similares